Ferroptosis: A new horizon in cancer therapy

Area of Science:

• Oncology
• Cell Death Research
• Cancer Therapeutics

Background:

• Ferroptosis is an iron-dependent cell death pathway driven by lipid peroxidation.
• Cancer cells can exploit ferroptosis pathways for survival, often through antioxidant adaptations.
• Understanding ferroptosis's dual role in tumor biology is crucial for developing new cancer treatments.

Purpose of the Study:

• To review the dual role of ferroptosis in tumor biology and its interaction with the tumor microenvironment.
• To explore therapeutic strategies involving ferroptosis induction for cancer treatment.
• To identify challenges and future directions for ferroptosis-based cancer therapies.

Main Methods:

• Literature review of ferroptosis in cancer biology and therapy.
• Analysis of ferroptosis's interplay with the tumor microenvironment and immune signaling.
• Discussion of synergistic therapeutic approaches combining ferroptosis induction with conventional and novel cancer treatments.

Main Results:

• Ferroptosis can suppress tumor progression but is often subverted by cancer cells.
• Ferroptosis induction can modulate both immunogenic cell death and immunosuppressive signaling within the tumor microenvironment.
• Synergistic strategies combining ferroptosis with chemotherapy, targeted therapy, radiotherapy, hyperthermia, and immunotherapy show promise.

Conclusions:

• Ferroptosis-based therapies offer innovative strategies to overcome treatment resistance and immune evasion in malignancies.
• Identifying predictive biomarkers and developing tumor-selective ferroptosis inducers are key challenges.
• Modulating ferroptosis-immune interactions within the tumor microenvironment is essential for maximizing therapeutic efficacy.